The blood glucose monitoring and data management company AgaMatrix and the digital health assistant developer LifeWallet announced a collaboration to bring AgaMatrix’s connected blood glucose monitoring solutions together with LifeWallet’s apps for health risk assessment and follow-up care, for improved outcomes in population health management.
CVS Health and Cleveland Clinic expanded their eight-year clinical affiliation to enhance access to care for patients throughout Northeast Ohio and Florida, and improve quality, coordinated delivery of care, and health outcomes for patients.
Smart Meter LLC received 510(k) clearance from FDA and CE Mark in Europe to market the company’s iGlucose Blood Glucose Monitoring System.
Responding to demands from cities across the country, NYU School of Medicine’s Department of Population Health, NYU’s Robert F. Wagner School of Public Service and the National Resource Network – with support from the Robert Wood Johnson Foundation – have launched the City Health Dashboard.
Purdue Pharma LP, Virginia Governor Terry McAuliffe, and the Virginia Secretary of Health and Human Resources have announced the formation of a private-public partnership to enhance utilization of the state prescription monitoring program as part of the solution to address the opioid crisis.
WPP announced the formation of WPP Health & Wellness, a new sub-holding company that unites WPP’s broad capability under one banner to significantly advance its offer and partnership with clients across the spectrum of health and wellness.
In honor of American Heart Month, AHA and OH launch new initiative to improve heart health outcomes.
It’s tough times on Medicine Avenue. But, by aiming to achieve one simple, straightforward metric, I’d argue we could turn every one of those challenges around. That metric is winning a Cannes Lion.
Recurring themes explored at Lions Health this year included empathy. The term was tossed around in all sorts of contexts – health bias, gaps in care, disease stigma, aging. For the most part, it was centered on better understanding between the health industry and people in health crisis. For me, as a creative leader and armchair strategist, empathy is most powerful in connecting ideas to audiences.
The latest innovation in oncology research is tying tumor biomarkers to specific treatments in order to improve patient outcomes. Med Ad News spoke with Gerald Messerschmidt, M.D., chief medical officer of Precision Oncology, to find out how the biomarker-treatment link will help get treatments to market, and to the right patients, faster.
